Almirall (ALMe)

Currency in EUR
10.65
0.00(0.00%)
Closed·
ALMe Scorecard
Full Analysis
Net income is expected to grow this year
ALMe is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.6510.65
52 wk Range
8.1911.24
Key Statistics
Bid/Ask
8.59 / 8.41
Prev. Close
10.65
Open
10.65
Day's Range
10.65-10.65
52 wk Range
8.19-11.24
Volume
-
Average Volume (3m)
2.02K
1-Year Change
12.49%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALMe Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Almirall News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Almirall Company Profile

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immunostimulants; metabolism; and systematic hormonal preparations. It has a multi-target partnership with Etherna to research and develop mRNA-based therapies for medical dermatology. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Employees
2026
Market
Spain

Compare ALMe to Peers and Sector

Metrics to compare
ALMe
Peers
Sector
Relationship
P/E Ratio
93.4x16.7x−0.5x
PEG Ratio
-0.040.00
Price/Book
1.5x4.0x2.6x
Price / LTM Sales
2.2x3.6x3.2x
Upside (Analyst Target)
-17.0%42.7%
Fair Value Upside
Unlock17.0%5.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.11%
Dividend Yield
1.40%
Industry Median 2.51%
Annualised payout
0.15
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 12, 2025
EPS / Forecast
0.10 / --
Revenue / Forecast
284.60M / 287.28M
EPS Revisions
Last 90 days

ALMe Income Statement

People Also Watch

37.210
IDR
-3.25%
7.3670
SAN
+2.25%
2.9325
SABE
+0.70%
13.277
ENAG
-2.34%
25.489
ELE
-3.45%

FAQ

What Stock Exchange Does Almirall Trade On?

Almirall is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for Almirall?

The stock symbol for Almirall is "ALMe."

What Is the Almirall Market Cap?

As of today, Almirall market cap is 2.26B.

What Is Almirall's Earnings Per Share (TTM)?

The Almirall EPS (TTM) is 0.11.

When Is the Next Almirall Earnings Date?

Almirall will release its next earnings report on 24 Jul 2025.

From a Technical Analysis Perspective, Is ALMe a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Almirall Stock Split?

Almirall has split 0 times.

How Many Employees Does Almirall Have?

Almirall has 2026 employees.

What is the current trading status of Almirall (ALMe)?

As of 23 Jul 2025, Almirall (ALMe) is trading at a price of 10.65, with a previous close of 10.65. The stock has fluctuated within a day range of 10.65 to 10.65, while its 52-week range spans from 8.19 to 11.24.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.